Analysed IMMUNOME INC (IMNM:NASDAQ) News Sources
A Look At Immunome (IMNM) Valuation As Varegacestat Nears ASCO 2026 Spotlight And FDA NDA Filing
25-04-2026
yahoo.com
Immunome Announces Submission of New Drug Application to U.S. FDA for Varegacestat for the Treatment of Adults with Desmoid Tumors
29-04-2026
yahoo.com
Assessing Immunome (IMNM) Valuation After Varegacestat NDA And Phase 3 Desmoid Tumor Success
11-05-2026
yahoo.com
Immunome, Inc. (IMNM) Reports Submission of an NDA for Varegacestat in Desmoid Tumors
12-05-2026
yahoo.com
Immunome Reports First Quarter 2026 Financial Results and Provides Business Update
12-05-2026
yahoo.com
What is the current price of IMMUNOME INC (IMNM:NASDAQ)?
The current price of IMMUNOME INC (IMNM:NASDAQ) is $21.91.
IMMUNOME INC (IMNM:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNOME INC (IMNM:NASDAQ) since the previous trading day is $0.25.
IMMUNOME INC (IMNM:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNOME INC (IMNM:NASDAQ) since the previous trading day is 1.1542%.
What is the most recent average sentiment score for IMMUNOME INC (IMNM:NASDAQ)?
The most recent average sentiment score for IMMUNOME INC (IMNM:NASDAQ) is 48 out of 100.
What is the most recent average sentiment for IMMUNOME INC (IMNM:NASDAQ)?
The most recent sentiment for IMMUNOME INC (IMNM:NASDAQ) is .
SEC-8K** Filing Available For IMMUNOME INC (IMNM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.